# Multicenter Validation of the English Version of the Dépistage Cognitif de Québec: a Cognitive Screening Tool for Atypical Dementias

**Authors:** Synthia Meilleur-Durand, Marianne Lévesque, Frederic St-Onge, Mario Masellis, Ging-Yuek Robin Hsiung, Pamela Jarrett, Sylvia Villeneuve, Gabriel Léger, David Salmon, Doug Galasko, Stephen C Cunnane, Serge Gauthier, Brandy Callahan, Leila Sellami, Carol Hudon, Joël Macoir, Louis Verret, Alison Cassivi-Joncas, Michael Comishen, Robert Laforce

PMC · DOI: 10.1093/arclin/acae092 · Archives of Clinical Neuropsychology · 2024-10-11

## TL;DR

This study validates an English version of a cognitive test designed to detect atypical dementias, showing it is reliable and effective for early diagnosis.

## Contribution

The English version of the Dépistage Cognitif de Québec is validated for use in detecting atypical dementias.

## Key findings

- The English DCQ showed strong correlation with the Montreal Cognitive Assessment and high reliability.
- The test is sensitive to atypical dementias like primary progressive aphasias and frontotemporolobar degeneration.
- Normative data were stratified by age and education for English-speaking controls aged 50 to 87.

## Abstract

Early detection of atypical dementia remains difficult partly because of the absence of specific cognitive screening tools. This creates undue delays in diagnosis and management. The Dépistage Cognitif de Québec (DCQ; dcqtest.org) was developed in French and later validated in participants with atypical syndromes. We report the validation of the English version.

This multicentre prospective validation study was conducted in 10 centers across Canada and the United States on 260 English-speaking participants aged over 50. We translated and modified the original French DCQ to add targeted stimuli to the Visusopatial Index and social cognition vignettes to the Behavioral Index. A backward translation was performed and equivalence between languages was assessed by administering both tests to 30 bilingual participants.

Mean DCQ total score (out of 100) was 95.0 (SD = 3.6). Spearman’s correlation coefficient showed a strong and significant correlation (r = 0.49, p < .001) with the Montreal Cognitive Assessment. Test–retest reliability was good (Spearman’s coefficient = 0.72, p < .001) and interrater reliability, excellent (intraclass correlation = 0.97, p < .001). Normative data shown in percentiles were stratified by age and education for a population-based sample of 260 English-speaking controls aged between 50 and 87 years old.

Similar to the French version, the English DCQ proved to be a valid cognitive screening test. The original version was very sensitive to detect atypical dementias such as primary progressive aphasias, Alzheimer’s disease’ variants and syndromes along the frontotemporolobar degeneration spectrum. This 20-min test can be administered à la carte and offers an alternative to detailed comprehensive neuropsychological evaluations.

## Linked entities

- **Diseases:** Alzheimer’s disease (MONDO:0004975)

## Full-text entities

- **Diseases:** Alzheimer's disease (MESH:D000544), frontotemporolobar degeneration (MESH:D009410), primary progressive aphasias (MESH:D018888), Dementias (MESH:D003704)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12034515/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12034515/full.md

## References

9 references — full list in the complete paper: https://tomesphere.com/paper/PMC12034515/full.md

---
Source: https://tomesphere.com/paper/PMC12034515